Form 4: Cytokinetics Executive Fady Ibraham Malik Reports Gift of Common Stock
SEC Form 4 Filing
EVP of Research & Development at Cytokinetics, Fady Ibraham Malik, reports a gift of 200 shares of common stock.
Summary
- On March 19, 2025, Fady Ibraham Malik, EVP of Research & Development at Cytokinetics Inc., reported a transaction involving the company's common stock.
- Malik gifted 200 shares of common stock.
- Following the transaction, Malik directly owns 140,255 shares of Cytokinetics Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of a stock transaction. It doesn't inherently indicate positive or negative sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/19/2025 | Date of transaction: gift of common stock |
Keywords
Form 4, Beneficial Ownership, CYTK, Cytokinetics Inc., Fady Ibraham Malik, Stock Gift, EVP Research & Development
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.